543 related articles for article (PubMed ID: 24461094)
41. Blastic plasmacytoid dendritic cell neoplasm presenting as leukemia without cutaneous involvement in a 25 years male patient: Unusual presentation of a rare entity.
Qayoom S; Durga G; George S; Rahman K
Indian J Pathol Microbiol; 2015; 58(3):377-80. PubMed ID: 26275271
[TBL] [Abstract][Full Text] [Related]
42. A CD56- immunoblastoid variant of blastic plasmacytoid dendritic cell neoplasm.
Aran BM; Duran J; Whittemore D; Gru AA
J Cutan Pathol; 2024 Jan; 51(1):40-44. PubMed ID: 37612885
[TBL] [Abstract][Full Text] [Related]
43. CD4+/CD56+ haematodermic neoplasm: a preculsor haematological neoplasm that frequently first presents in the skin.
Martín JM; Nicolau MJ; Galán A; Ferrández-Izquierdo A; Ferrer AM; Jordá E
J Eur Acad Dermatol Venereol; 2006 Oct; 20(9):1129-32. PubMed ID: 16987271
[TBL] [Abstract][Full Text] [Related]
44. Blastic Plasmacytoid Dendritic Cell Neoplasm.
Jain A; Sweet K
J Natl Compr Canc Netw; 2023 May; 21(5):515-521. PubMed ID: 37156483
[TBL] [Abstract][Full Text] [Related]
45. Immunophenotypic analysis of myeloperoxidase-negative leukemia cutis and blastic plasmacytoid dendritic cell neoplasm.
Cronin DM; George TI; Reichard KK; Sundram UN
Am J Clin Pathol; 2012 Mar; 137(3):367-76. PubMed ID: 22338048
[TBL] [Abstract][Full Text] [Related]
46. Human BDCA2+CD123+CD56+ dendritic cells (DCs) related to blastic plasmacytoid dendritic cell neoplasm represent a unique myeloid DC subset.
Yu H; Zhang P; Yin X; Yin Z; Shi Q; Cui Y; Liu G; Wang S; Piccaluga PP; Jiang T; Zhang L
Protein Cell; 2015 Apr; 6(4):297-306. PubMed ID: 25779340
[TBL] [Abstract][Full Text] [Related]
47. A critical review of treatment modalities for blastic plasmacytoid dendritic cell neoplasm.
Falcone U; Sibai H; Deotare U
Crit Rev Oncol Hematol; 2016 Nov; 107():156-162. PubMed ID: 27823644
[TBL] [Abstract][Full Text] [Related]
48. L-asparaginase with methotrexate and dexamethasone is an effective treatment combination in blastic plasmacytoid dendritic cell neoplasm.
Gruson B; Vaida I; Merlusca L; Charbonnier A; Parcelier A; Damaj G; Royer B; Marolleau JP
Br J Haematol; 2013 Nov; 163(4):543-5. PubMed ID: 23937331
[No Abstract] [Full Text] [Related]
49. [Sustained remission of blastic plasmacytoid dendritic cell neoplasm with ABVD chemotherapy].
Tanikawa S; Sakuranaka H; Chong JM; Okada Y; Takimoto M
Rinsho Ketsueki; 2012 Feb; 53(2):246-51. PubMed ID: 22450587
[TBL] [Abstract][Full Text] [Related]
50. Clinical and biologic features of CD4(+)CD56(+) malignancies.
Feuillard J; Jacob MC; Valensi F; Maynadié M; Gressin R; Chaperot L; Arnoulet C; Brignole-Baudouin F; Drénou B; Duchayne E; Falkenrodt A; Garand R; Homolle E; Husson B; Kuhlein E; Le Calvez G; Sainty D; Sotto MF; Trimoreau F; Béné MC
Blood; 2002 Mar; 99(5):1556-63. PubMed ID: 11861268
[TBL] [Abstract][Full Text] [Related]
51. [Hematodermic CD4+ CD56+ neoplasm in childhood].
Bilbao EA; Chirife AM; Florio D; Giménez LB; Marino L; Rosso DA
Medicina (B Aires); 2008; 68(2):147-50. PubMed ID: 18499965
[TBL] [Abstract][Full Text] [Related]
52. Blastic plasmacytoid dendritic cell neoplasm: A clinicopathological diagnostic dilemma report of three cases with review of literature.
Purkait S; Gupta S; Bakhshi S; Mallick S
J Cancer Res Ther; 2022 Dec; 18(Supplement):S471-S474. PubMed ID: 36511007
[TBL] [Abstract][Full Text] [Related]
53. [Rare diagnosis of CD4+56+ leukemia from dendritic cells type DC2].
Klabusay M; Pevná M; Kissová J; Doubek M; Heidekerová M; Mayer J; Vorlícek J
Cas Lek Cesk; 2008; 147(10):511-5. PubMed ID: 19177732
[TBL] [Abstract][Full Text] [Related]
54. Blastic plasmacytoid dendritic cell neoplasm (BPDCN) in leukaemic phase without skin lesions: a diagnostic and management challenge.
Murphy N; Owens D; Hinds E; Nelson N
Pathology; 2019 Jun; 51(4):439-441. PubMed ID: 31003841
[No Abstract] [Full Text] [Related]
55. Blastic Plasmacytoid Dendritic Cell Neoplasm with Pulmonary Involvement and Atypical Skin Lesion.
Barros Romão CMDS; Santos Júnior CJD; Leite LAC; Gomes Alves MJR; Araújo NS; Castro AFL; Moura MS; Gomes VMDS; Sampaio Batinga AMC; Queiroz JAS; Dos Santos NB
Am J Case Rep; 2017 Jun; 18():692-695. PubMed ID: 28635683
[TBL] [Abstract][Full Text] [Related]
56. CD4+/CD56+ hematodermic neoplasm ("blastic natural killer cell lymphoma"): neoplastic cells express the immature dendritic cell marker BDCA-2 and produce interferon.
Pilichowska ME; Fleming MD; Pinkus JL; Pinkus GS
Am J Clin Pathol; 2007 Sep; 128(3):445-53. PubMed ID: 17709319
[TBL] [Abstract][Full Text] [Related]
57. Myeloid Cell Nuclear Differentiation Antigen (MNDA) Expression Distinguishes Extramedullary Presentations of Myeloid Leukemia From Blastic Plasmacytoid Dendritic Cell Neoplasm.
Johnson RC; Kim J; Natkunam Y; Sundram U; Freud AG; Gammon B; Cascio MJ
Am J Surg Pathol; 2016 Apr; 40(4):502-9. PubMed ID: 26796502
[TBL] [Abstract][Full Text] [Related]
58. Optimized immunohistochemical panel to differentiate myeloid sarcoma from blastic plasmacytoid dendritic cell neoplasm.
Sangle NA; Schmidt RL; Patel JL; Medeiros LJ; Agarwal AM; Perkins SL; Salama ME
Mod Pathol; 2014 Aug; 27(8):1137-43. PubMed ID: 24390220
[TBL] [Abstract][Full Text] [Related]
59. Pediatric blastic plasmacytoid dendritic cell neoplasm: report of four cases and review of literature.
Liao C; Hu NX; Song H; Zhang JY; Shen DY; Xu XJ; Tang YM
Int J Hematol; 2021 May; 113(5):751-759. PubMed ID: 33392975
[TBL] [Abstract][Full Text] [Related]
60. Blastic plasmacytoid dendritic cell neoplasm: a report of four cases and review of the literature.
Borchiellini D; Ghibaudo N; Mounier N; Del Giudice P; Quinsat D; Ticchioni M; Perrin C; Cardot Leccia N; Lacour JP
J Eur Acad Dermatol Venereol; 2013 Sep; 27(9):1176-81. PubMed ID: 22455538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
